# EDGAR Filing Document

**Accession Number:** 0001883788
**File Stem:** 0001641172-25-017276
**Filing Date:** 2025-7
**Character Count:** 11995
**Document Hash:** 1ef0ad92da437fe6e451074714f40e0a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-017276.hdr.sgml**: 20250701

**ACCESSION NUMBER**: 0001641172-25-017276

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20250701

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250701

**DATE AS OF CHANGE**: 20250701

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DIH HOLDING US, INC.
- **CENTRAL INDEX KEY:** 0001883788
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41250
- **FILM NUMBER:** 251094192

**BUSINESS ADDRESS:**
- **STREET 1:** 77 ACCORD PARK DRIVE, SUITE D-1
- **CITY:** NORWELL
- **STATE:** MA
- **ZIP:** 02061
- **BUSINESS PHONE:** 877-944-2200

**MAIL ADDRESS:**
- **STREET 1:** 77 ACCORD PARK DRIVE, SUITE D-1
- **CITY:** NORWELL
- **STATE:** MA
- **ZIP:** 02061

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Aurora Technology Acquisition Corp.
- **DATE OF NAME CHANGE:** 20210917

?xml version='1.0' encoding='ASCII'?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION** **WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): July 1, 2025**

**DIH HOLDING US, INC.**

**(Exact name of Registrant as Specified in Its Charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41250** | **98-1624542** |
| **(State or Other Jurisdiction<br> of Incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer<br> Identification No.)** |

---

---

| | |
|:---|:---|
| **77 Accord Park Drive;**<br> **Suite D-1** |  |
| **Norwell, Massachusetts** | **02061** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code: 877 944-2200**

**Not Applicable**

**(Former Name or Former Address, if Changed Since Last Report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Class A Common Stock | DHAI | The Nasdaq Stock Market LLC |
| Warrants | DHAIW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 7.01 Regulation FD Disclosure**

On July 1, 2025, DIH Holding US, Inc. (the "Registrant") issued a press release announcing the designation of a new Center of Excellence. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

**Item 9.01 Financial Statements and Exhibits.**

*(a)-(b) Financial Statements.*

*(c) Exhibits.*

 

99.1 [Release dated July 1, 2025](ex99-1.htm) <br> 104 Cover Page Interactive Data File (Formatted in Inline XBRL)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | DIH HOLDING US, INC. | DIH HOLDING US, INC. |
| Date: | July 1, 2025 | By: | */s/ Jason Chen* |
|  |  |  | Jason Chen<br> Chief Executive Officer and Chairman |

---

## Exhibit 99.1

**Exhibit 99.1**

**DIH Appoints Rehazentrum Valens as a DIH Center of Excellence**

**Norwell, MA and Zürich, CH, July 1, 2025** — DIH HOLDING US, Inc. ("DIH") (NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Rehazentrum Valens, a member of the Kliniken Valens group, as a DIH Center of Excellence. Through this partnership, DIH and the Kliniken Valens group reinforce their commitment to transforming rehabilitation by leveraging innovation to improve patient outcomes and support the recovery journey.

The DIH Center of Excellence program recognizes strategic partners that showcase best practices in rehabilitation robotics while demonstrating how DIH therapy solutions contribute to successful patient outcomes. These Centers also contribute to the development of advanced rehabilitation technologies.

Established in 1970, Rehazentrum Valens is one of Switzerland's leading rehabilitation centers specializing in neurological, musculoskeletal, and internal medicine rehabilitation. Located in a serene alpine setting, it offers state-of-the-art medical care, innovative therapies, and personalized treatment programs aimed at restoring patients' independence and quality of life. With a strong focus on interdisciplinary collaboration and patient-centered care, Rehazentrum Valens is recognized for its excellence in both clinical outcomes and holistic recovery.

Rehazentrum Valens utilizes DIH's Total Solution, including Erigo®Pro for early mobilization, Lokomat®Pro for intensive gait training, Andago® for overground gait training, and C-Mill VR+ for balance and gait adaptability training. In addition, an effective set-up of the complete Armeo® product family, featuring Armeo®Power, Armeo®Spring, and Armeo®Senso, supports advanced arm and hand therapy, catering to a wide range of patient needs, from acute to mild. These devices complement the hospital's extensive therapy programs, reflecting its commitment to the highest standards in modern neurorehabilitation.

"It is an honor to welcome Rehazentrum Valens as a DIH Center of Excellence," said Andrés Bataszew, International Sales Director at DIH – Direct Markets. "Renowned for its leadership in evidence-based rehabilitation and its multidisciplinary approach, Rehazentrum Valens exemplifies clinical excellence and innovation. Their commitment to integrating advanced technologies into patient care reflects our shared vision of transforming rehabilitation outcomes. This recognition marks a significant step in our collaboration, and together, we will continue to shape the future of rehabilitation."

"As a rehabilitation center with a strong focus on interdisciplinary and evidence-based therapy, we are honored to be recognized as a DIH Center of Excellence," emphasizes Daniel Riese, Head of Therapies at Rehazentrum Valens. "More than 20 years ago, we laid the foundation for robotic-assisted rehabilitation in Valens by implementing one of the first Lokomat systems. Since then, we have continuously developed and expanded this approach – always with the aim of supporting patients purposefully and effectively throughout their rehabilitation journey. Our partnership with DIH strengthens our ability to integrate advanced technologies responsibly into established clinical care pathways."

 

**About DIH Holding US, Inc.**

DIH stands for the vision to "Deliver Inspiration & Health" to improve the functioning of millions of people with disability and functional impairments. DIH is a global solution provider in blending innovative robotic and virtual reality ("VR") technologies with clinical integration and insights. Built through the mergers of global-leading niche technologies providers, DIH is positioning itself as a transformative total smart solutions provider and consolidator in a largely fragmented and manual-labor-driven industry.

**About Rehazentrum Valens**

Rehazentrum Valens, a premier rehabilitation center with 150 beds and approximately 400 employees, is located above Bad Ragaz, just 1.5 hours from Zurich. The rehabilitation clinic specializes in treating patients with functional impairments of the musculoskeletal and nervous systems. With a strong emphasis on interdisciplinary collaboration, their expert teams design personalized, evidence-based rehabilitation programs tailored to each patient's unique needs.

Renowned for its clinical excellence and depth of expertise, Rehazentrum Valens enjoys a distinguished international reputation and ranks among Switzerland's leading rehabilitation institutions.

**About Kliniken Valens**

With ten inpatient and three exclusively outpatient rehabilitation centers across Switzerland, the Valens clinics (Kliniken Valens) are recognized among the country's leading hospitals. They offer top-tier expertise across a wide range of specialties, including neurological, musculoskeletal, internal medicine and oncology, cardiology, pulmonology, geriatric rehabilitation, psychosomatic rehabilitation, and psychiatry.

Understanding that a hospital stay can be a challenging and unfamiliar experience for patients and their families, Kliniken Valens is committed to providing compassionate support throughout this journey. Their goal is to help patients navigate these challenges successfully, achieve their rehabilitation objectives, and return to their families, communities, and workplaces as quickly and fully as possible.

**Caution Regarding Forward-Looking Statements**

This press release contains certain statements which are not historical facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect to the business combination, the services offered by DIH and the markets in which it operates, and DIH's projected future results. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions provided for illustrative purposes only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; the ability of DIH to achieve its projected revenue, the failure of DIH realize the anticipated benefits of the recently-completed business combination and access to sources of additional debt or equity capital if needed. While DIH may elect to update these forward-looking statements at some point in the future, DIH specifically disclaims any obligation to do so.

**Investor Contact**

Greg Chodaczek

**Email:** Investor.relations@dih.com